Can a 14‑year‑old safely take bismuth subsalicylate (Pepto‑Bismol) and what dose should be used?

Bismuth Subsalicylate Use in 14-Year-Olds

A 14-year-old can safely take bismuth subsalicylate at the adult dose of 30 mL (262 mg tablets: 2 tablets) every 30–60 minutes as needed, not exceeding 240 mL (8 doses) in 24 hours, but only if they are NOT recovering from influenza or varicella due to Reye's syndrome risk. 1

Critical Safety Consideration: Reye's Syndrome

• Absolute contraindication: Bismuth subsalicylate contains salicylate and must be avoided in children and teenagers with active or recent influenza or chickenpox (varicella) infections due to the established association between salicylates and Reye's syndrome—a rare but potentially fatal condition causing acute encephalopathy and hepatic failure. 1

• Screen before prescribing: Explicitly ask whether the 14-year-old has had flu-like symptoms, confirmed influenza, or varicella exposure in the preceding 2–3 weeks. If yes, choose a non-salicylate alternative (e.g., loperamide for diarrhea).

FDA-Approved Dosing for Ages 12 and Older

• Standard dose: 30 mL of liquid formulation (or 2 tablets of 262 mg bismuth subsalicylate) every 30 minutes to 1 hour as needed. 1

• Maximum daily dose: Do not exceed 8 doses (240 mL total or 16 tablets) in 24 hours. 1

• Duration: Use until diarrhea stops, but not longer than 2 days without medical consultation. 1

• Hydration: Emphasize drinking plenty of clear fluids to prevent dehydration, especially with diarrhea. 1

Evidence for Efficacy in Adolescents and Children

• Acute diarrhea treatment: Multiple randomized controlled trials in children (ages 4 months to 5 years) demonstrated that bismuth subsalicylate at 100 mg/kg/day significantly reduced stool frequency, stool volume, and duration of hospitalization compared to placebo, with no adverse effects or toxic salicylate/bismuth levels. 2, 3

• Safety in younger children: Studies using doses up to 150 mg/kg/day in infants and toddlers found serum salicylate and bismuth concentrations remained well below toxic thresholds, with no serious adverse reactions reported. 2, 4

• Extrapolation to adolescents: Since the FDA approves adult dosing for patients ≥12 years, and pediatric studies show safety at weight-based doses far exceeding the adult fixed dose when normalized per kilogram, a 14-year-old can safely use the standard adult regimen. 1, 2

Common Pitfalls and How to Avoid Them

• Mistaking for antibiotic: Bismuth subsalicylate is an antimicrobial adjunct with bacteriostatic properties against enteric pathogens (including E. coli, Salmonella, Shigella, and C. difficile), but it is not a substitute for antibiotics when indicated. 5

• Chronic use toxicity: Prolonged daily use (weeks to months) can cause chronic salicylate toxicity, presenting as confusion, tinnitus, and hearing impairment—especially in elderly patients, but theoretically possible in adolescents. 6 Limit use to 2 days for self-treatment; refer if symptoms persist. 1

• Black stool/tongue: Warn patients and parents that harmless darkening of stool and tongue is expected due to bismuth sulfide formation in the GI tract; this does not indicate bleeding.

• Drug interactions: Salicylate component may interact with anticoagulants, methotrexate, and other salicylate-containing products. Review the medication list before prescribing.

When to Choose Bismuth Subsalicylate

• Acute infectious diarrhea: Particularly traveler's diarrhea or food-borne illness where antimicrobial activity against common bacterial pathogens is beneficial. 7, 5

• Mild gastroenteritis symptoms: Nausea, heartburn, indigestion, and upset stomach in addition to diarrhea. 1

• Adjunct to oral rehydration: Bismuth subsalicylate reduces stool output and oral rehydration solution requirements, shortening illness duration. 2, 3

When to Avoid Bismuth Subsalicylate

• Influenza or varicella: Any suspicion of viral illness with these pathogens mandates avoidance. 1

• Aspirin allergy: Cross-reactivity with salicylates makes this contraindicated.

• Severe dehydration or systemic illness: Requires medical evaluation and potentially intravenous rehydration, not self-treatment.

• Concurrent salicylate use: Avoid doubling salicylate exposure (e.g., aspirin for another indication).